Literature DB >> 12461028

Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Laurent Poirel1, Marek Gniadkowski, Patrice Nordmann.   

Abstract

The extended-spectrum beta-lactamase CTX-M-15 confers resistance to ceftazidime, unlike the majority of CTX-M-type enzymes. Kinetic parameters were determined from purified CTX-M-15 and CTX-M-3, which differ by the single amino acid substitution Asp-240 to Gly, according to the Ambler numbering of class A beta-lactamases. Relative molecular masses of CTX-M-15 and CTX-M-3 were approximately 29 kDa and pI values were 8.9 and 8.4, respectively. CTX-M-15 had higher affinities for beta-lactams (lower K(m) values) than those of CTX-M-3 but catalytic efficiency (k(cat)/K(m) values) was variable depending on the beta-lactam substrate. Only CTX-M-15 showed a measurable catalytic efficiency for ceftazidime. Clavulanic acid and tazobactam were good inhibitors of both enzymes. MICs of beta-lactams for Escherichia coli reference strains expressing cloned beta-lactamase genes in the same genetic background were similar except for ceftazidime. This work underlines the fact that some CTX-M enzymes may hydrolyse ceftazidime and thus confer resistance to this expanded-spectrum cephalosporin in Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461028     DOI: 10.1093/jac/dkf240

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  95 in total

1.  Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 beta-lactamase in Taiwan.

Authors:  Wen-Liang Yu; Kuo-Chen Cheng; Lii-Tzu Wu; Michael A Pfaller; Patricia L Winokur; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 2.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.

Authors:  Monica Cartelle; Maria del Mar Tomas; Francisca Molina; Rita Moure; Rosa Villanueva; German Bou
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Increased resistance rate to ceftazidime among blood culture isolates of ESBL-producing Escherichia coli in a university-affiliated hospital of China.

Authors:  Xiao-Yan Yuan; Dong-Ying Yu; Xue-Hong Qu; Xin-Qiang Xiao; Bo Bi; Sheng-Bo Sun; Ai-Ying Chang; Qi-bo Zhang
Journal:  J Antibiot (Tokyo)       Date:  2015-09-30       Impact factor: 2.649

5.  Molecular and kinetic comparison of the novel extended-spectrum beta-lactamases CTX-M-25 and CTX-M-26.

Authors:  Craig J Munday; David A Boyd; Nigel Brenwald; Mark Miller; Jennifer M Andrews; Richard Wise; Michael R Mulvey; Peter M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Acquisition of Broad-Spectrum Cephalosporin Resistance Leading to Colistin Resistance in Klebsiella pneumoniae.

Authors:  Aurélie Jayol; Patrice Nordmann; Marine Desroches; Jean-Winoc Decousser; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

7.  Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.

Authors:  Yukiko Nagano; Noriyuki Nagano; Jun-ichi Wachino; Keiko Ishikawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

8.  Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.

Authors:  Ståle Tofteland; Bjørg Haldorsen; Kristin H Dahl; Gunnar S Simonsen; Martin Steinbakk; Timothy R Walsh; Arnfinn Sundsfjord
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

9.  Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.

Authors:  David A Boyd; Shaun Tyler; Sara Christianson; Allison McGeer; Matthew P Muller; Barbara M Willey; Elizabeth Bryce; Michael Gardam; Patrice Nordmann; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.

Authors:  Véronique Leflon-Guibout; Cécile Jurand; Stéphane Bonacorsi; Florence Espinasse; Marie Claude Guelfi; Françoise Duportail; Beate Heym; Edouard Bingen; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.